LABD.US is a triple-leveraged inverse ETF. Underlying Index: The performance of the S&P Biotechnology Select Industry Index significantly impacts LABD.US. This index tracks a basket of biotechnology companies.

Leverage: Being triple-leveraged, LABD.US amplifies the daily percentage changes of the underlying index. A small movement in the index results in a larger, opposite movement in LABD.US.

Inverse Relationship: LABD.US is designed to move in the opposite direction of the index. If the index rises, LABD.US is expected to fall, and vice versa.

Biotech Sector Sentiment: Overall investor sentiment towards the biotechnology sector influences the underlying index. Positive news for the biotech industry will likely decrease the value of LABD.US.

Rebalancing: LABD.US needs to rebalance its portfolio daily to maintain its 3x leverage and inverse exposure. This rebalancing process can impact the ETF's price, especially in volatile markets.

Time Decay: Due to daily rebalancing, LABD.US suffers from time decay, also known as volatility drag. This means that over long periods, even if the underlying index stays relatively flat, LABD.US can lose value.

Interest Rates: Changes in interest rates can influence the cost of borrowing for the ETF, potentially affecting its returns.

ETF Supply and Demand: Like any other ETF, the supply and demand for LABD.US shares can influence its market price.

Management Fees and Expenses: The ETF's expense ratio and management fees are deducted from its returns, impacting its overall performance.